Medicure is a Winnipeg-based pharmaceutical company focused on the development, acquisition, and commercialization of medicines for the U.S. market. The company’s current commercial focus centers on cardiovascular and related healthcare products, including AGGRASTAT and ZYPITAMAG, while also expanding through pharmacy and distribution businesses. Medicure operates as a Canadian public company with a U.S.-focused specialty pharma model.